跳至主要内容
临床试验/ISRCTN88882979
ISRCTN88882979
已完成
不适用

HTA Study of Antidepressants for Depression in Dementia: A definitive multi-centre pragmatic randomised controlled double-blind trial of the clinical and cost effectiveness of mirtazapine and sertraline versus placebo for the treatment of depression in dementia presenting in secondary care

King's College London (UK)0 个研究点目标入组 507 人2006年3月2日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Depression in dementia
发起方
King's College London (UK)
入组人数
507
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2006年3月2日
结束日期
待定
最后更新
11年前
研究类型
Interventional
性别
All

研究者

发起方
King's College London (UK)

入排标准

入选标准

  • We have designed this study as a pragmatic trial of effectiveness in routine clinical practice. We wish to minimise exclusions from the study in order to maximise the generalisability of the data generated.
  • The criteria for inclusion are set to be as close to clinical practice as possible. For this reason we do not specify the use of anything other than clinical diagnoses of dementia and depression since standardised instruments (other than the Mini\-Mental State Examination \[MMSE] as a measure of severity) are not used in routine practice. A detailed characterisation of cases using standardised tools will be completed at the research assessment. We will recruit those in whom a secondary care doctor makes at the point of referral to the RW:
  • 1\. A clinical diagnosis of mild to moderate probable or possible Alzheimer's Disease
  • 2\. A co\-existing depressive illness likely to need treatment with antidepressants
  • 3\. Depression should have a duration of more than four weeks

排除标准

  • We wish to minimise exclusions. We will exclude from the trial those in whom a secondary care doctor finds at the point of referral to the RW are:
  • 1\. Currently taking antidepressants
  • 2 Those with severe dementia (defined as MMSE \>7\)
  • 3\. The case is considered as being too critical to be randomised (e.g. because of suicide risk)
  • 4\. Displays absolute contraindications to one or more of the trial treatments
  • 5\. Not in another trial
  • 6\. Those where there is no identifiable family carer or other informant (e.g. a formal/professional carer who spends sufficient time with the person with dementia to be able to give an informed opinion) to give collateral information
  • We will further exclude from the trial those in whom the RW finds have a Cornell score \<8 at the point of randomisation.

结局指标

主要结局

未指定

相似试验